secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2026-09-16T12:00:14+00:00
Accession:  0001213900-26-100350
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity wins Japanese patent for stenoparib DRP companion diagnostic; Japan protection runs to 2039
--------------------------------------------------------------------------------

- Japan Patent Office granted Japanese Patent No. 7917283 covering stenoparib-specific DRP companion diagnostic; Japan protection extends into 2039.
- Patent covers DRP methods predicting clinical benefit from stenoparib via tumor gene-expression profiles and patient-selection methods.
- Prior stenoparib DRP protection secured in US through April 2042, plus selected European jurisdictions and Australia; other filings pending.
- CEO Thomas Jensen cites Japan as key pharma market and home of Eisai, original stenoparib developer, supporting drug's developability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026100350/0001213900-26-100350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026100350/ea0305570-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-100350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer